We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
Sekisui Diagnostics

Download Mobile App




Surgery Should Be Primary Treatment for Achalasia

By HospiMedica International staff writers
Posted on 22 Aug 2012
Surgery should be the primary treatment for patients with achalasia, despite higher morbidity than observed with endoscopy, according to a new study.

Researchers at the University of Chicago (IL, USA) conducted a retrospective study in which they analyzed electronic medical records (EMRs) from 148 patients with achalasia between January 1, 2000, and August 9, 2011, to determine the efficacy of endoscopic versus surgical treatments. More...
In the surgical group, 72 patients underwent surgical myotomy with or without a full or partial fundoplication. Eight of those patients (11%) had more than one surgical admission, and 23 patients (32%) had undergone prior endoscopic treatment.

In the endoscopic group, 76 patients underwent only endoscopic treatments, which included balloon dilation, botulinum injection or both; 53 of those patients (70%) had more than one treatment, which came to 174 endoscopic interventions total. The investigators noted no statistically significant differences between the demographics, except that patients in the surgical cohort were significantly younger (56.3 versus 72.7 years).

The results showed that the average time between the first and second surgery was almost seven times longer than that for endoscopic procedures. Patients in the endoscopic group underwent a mean of three interventions and had significantly more dysphagia and gastroesophageal reflux disease (GERD)-related symptoms than the surgical group. The 30-day morbidity rate in the surgical group, however, was more than four times greater than that in the endoscopy group (6.9% versus 1.3% patients, respectively); deaths did not occur in either group. The study was presented at Digestive Disease Week (DDW), held during May 2012 in San Diego (CA, USA).

“Surgery is more efficacious than endoscopy alone because there is better resolution of achalasia and maybe even better treatment of the reflux,” said study investigator Michael Ujiki, MD, a clinical assistant professor of surgery. “If you look at this issue overall, the endoscopic surgeries end up costing more because of all the subsequent repeat interventions that may be required.”

Achalasia is an esophageal motility disorder involving the smooth muscle layer of the esophagus and the lower esophageal sphincter (LES). It is characterized by incomplete LES relaxation, increased LES tone, and lack of peristalsis of the esophagus. Achalasia is characterized by difficulty swallowing, regurgitation, and sometimes chest pain. Various treatments are available, although none cures the condition. Certain medications or Botox may be used in some cases, but more permanent relief is brought by esophageal dilatation and surgical cleaving of the muscle.

Related Links:

University of Chicago




Gold Member
12-Channel ECG
CM1200B
Radiology Monitor
MDNC-6121 Barco Nio Color 5.8MP
Multi-Chamber Washer-Disinfector
WD 390
Hybrid Arch Device
Neo EDE
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Artificial Intelligence

view channel
Image: Clinical LLM Performance Improves by >300% When Provided with High-Quality Real-World Evidence in New Precision Medicine Benchmark (Photo courtesy of Atropos Health)

New Benchmark Highlights Evidence Gaps in AI Responses to Clinical Questions

Many clinical decisions still rely on limited evidence, while most artificial intelligence benchmarks overlook the patient context that shapes real-world care. General large language models can also struggle... Read more

Point of Care

view channel
Image Credit: 123RF

Continuous Glucose Monitoring Identifies Cardiometabolic Risk in Adults Without Diabetes

Dysglycemia—abnormal blood glucose regulation—can fluctuate throughout the day and often escape conventional screening. Clinicians typically rely on fasting plasma glucose and hemoglobin A1c, which offer... Read more

Business

view channel
Image: LigaSure RAS Maryland, designed for the Valleylab FT10 platform on Hugo RAS, seals and cuts vessels, tissue, and lymphatics up to 7 mm in diameter (Photo courtesy of Medtronic)

Medtronic Receives FDA Clearance for Vessel-Sealing Instrument for Robotic Surgery

As robotic-assisted surgery expands across U.S. hospitals, teams increasingly seek energy instruments with the familiarity and performance of tools used in open and laparoscopic procedures.... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.